XML 18 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information
 12 Months Ended
Dec. 31, 2022
shares
Document Information [Line Items]  
Document Type 20-F
Document Registration Statement false
Document Shell Company Report false
Document Annual Report true
Document Transition Report false
Document Period End Date Dec. 31, 2022
Entity File Number 001-40241
Entity Registrant Name LAVA Therapeutics NV
Entity Incorporation, State or Country Code P7
Entity Address, Country NL
Entity Address, Address Line One Yalelaan 62
Entity Address, Adress Line Two CM
Entity Address, City or Town Utrecht
Entity Address, Postal Zip Code 3584
Title of 12(b) Security Common shares, par value $0.14 per share
Trading Symbol LVTX
Security Exchange Name NASDAQ
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 26,289,087
Entity Central Index Key 0001840748
Current Fiscal Year End Date --12-31
Document Fiscal Year Focus 2022
Document Fiscal Period Focus FY
Amendment Flag false
ICFR Auditor Attestation Flag false
Document Accounting Standard International Financial Reporting Standards
Auditor Name drs. J.W. Middelweerd RA
Auditor Firm ID 1395
Auditor Location Utrecht, The Netherlands
Business Contact [Member]  
Document Information [Line Items]  
Entity Address State Or Province PA
Entity Address, Address Line One 520 Walnut St
Entity Address, Adress Line Two Suite 1150
Entity Address, City or Town Philadelphia
Entity Address, Postal Zip Code PA 19106
Contact Personnel Email Address ir@lavatherapeutics.com
Contact Personnel Name Lava Therapeutics, Inc